Por favor, use este identificador para citar o enlazar este ítem: https://repositorio.uca.edu.ar/handle/123456789/11230
Título : Boron neutron capture therapy (BNCT) translational studies in the hamster cheek pouch model of oral cancer at the new “B2” configuration of the RA‑6 nuclear reactor
Autor : Monti Hughes, Andrea 
Longhino, Juan 
Boggio, Esteban 
Medin, Vanina A. 
Martinel Lamas, Diego José 
Heber, Elisa M. 
Pozzi, Emiliano C. C. 
Itoiz, María E. 
Aromando, Romina F. 
Nigg, David W. 
Trivillin, Verónica A. 
Schwint, Amanda E. 
Garabalino, Marcela A. 
Palabras clave : TERAPIA DE CAPTURA DE NEUTRONES DE BORO (BNCT)CONFIGURACION RA-6BOLSA DE MEJILLA DE HAMSTER MODELO DE CÁNCER ORALMUCOSITISHISTAMINATEJIDO PRECANCEROSO
Fecha de publicación : 2017
Editorial : Springer Nature
Cita : Monti Hughe, A., Longhino, J., Boggio, E., Medin, V. A., Martinel Lamas, D. J., Garabalin, M. A., Heber, E. M., Pozzi, E. C. C., Itoiz, M. E., Aromando, R. F., Nigg, D. W., Trivillin, V. A., Schwint, A. E. Boron neutron capture therapy (BNCT) translational studies in the hamster cheek pouch model of oral cancer at the new “B2” configuration of the RA‑6 nuclear reactor [en línea]. 2017. Radiat Environ Biophys 56 (4). Disponible en: https://repositorio.uca.edu.ar/handle/123456789/11230
Resumen : Abstract: Boron neutron capture therapy (BNCT) is based on selective accumulation of B-10 carriers in tumor followed by neutron irradiation. We demonstrated, in 2001, the thera- peutic effect of BNCT mediated by BPA (boronophenyla- lanine) in the hamster cheek pouch model of oral cancer, at the RA-6 nuclear reactor. Between 2007 and 2011, the RA-6 was upgraded, leading to an improvement in the per- formance of the BNCT beam (B2 configuration). Our aim was to evaluate BPA-BNCT radiotoxicity and tumor control in the hamster cheek pouch model of oral cancer at the new “B2” configuration. We also evaluated, for the first time in the oral cancer model, the radioprotective effect of histamine against mucositis in precancerous tissue as the dose-limiting tissue. Cancerized pouches were exposed to: BPA-BNCT; BPA-BNCT + histamine; BO: Beam only; BO + histamine; CONTROL: cancerized, no-treatment. BNCT induced severe mucositis, with an incidence that was slightly higher than in “B1” experiments (86 vs 67%, respectively). BO induced low/moderate mucositis. Histamine slightly reduced the incidence of severe mucositis induced by BPA-BNCT (75 vs 86%) and prevented mucositis altogether in BO animals. Tumor overall response was significantly higher in BNCT (94– 96%) than in control (16%) and BO groups (9–38%), and did not differ significantly from the “B1” results (91%). Histamine did not compromise BNCT therapeutic efficacy. BNCT radiotoxicity and therapeutic effect at the B1 and B2 configurations of RA-6 were consistent. Histamine slightly reduced mucositis in precancerous tissue even in this overly aggressive oral cancer model, without compromising tumor control.
URI : https://repositorio.uca.edu.ar/handle/123456789/11230
Disciplina: MEDICINA
DOI: 10.1007/s00411-017-0710-9
Derechos: Acceso abierto
Aparece en las colecciones: Artículos

Ficheros en este ítem:
Fichero Descripción Tamaño Formato
boron-neutron-capture-therapy.pdf1,17 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro Dublin Core completo del ítem

Visualizaciones de página(s)

129
comprobado en 28-mar-2024

Descarga(s)

332
comprobado en 28-mar-2024

Google ScholarTM

Consultar


Altmetric


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons